Labs nationwide are struggling to meet the processing demands of surging coronavirus disease 2019 (COVID-19) tests, causing long delays; levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, were found to drop dramatically across the first 3 months of infection; suspected opioid-related overdoses have more than doubled in Wisconsin amid the pandemic.
Reported by The Associated Press, labs nationwide are struggling to meet the processing demands of surging coronavirus disease 2019 (COVID-19) tests, causing long delays that experts note is affecting the pandemic response. As of Wednesday, the number of confirmed US COVID-19 cases has approached nearly 4 million, with states such as California and Florida experiencing all-time highs in daily case tolls. These surges have caused significant workloads for US labs, which can cause testing result lags of up to 2 weeks.
In findings from a research letter published this week in the New England Journal of Medicine, levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, dropped dramatically across the first 3 months of infection. Reported by CIDRAP, those examined experienced mild illness, with antibody levels indicated to decrease by about half every 73 days. At this rate, researchers note that antibody resistance would be depleted within a year. However, experts in a separate article published in The New York Times note that the possibility of being infected again with COVID-19 is very unlikely, although the long-term possibility is still unknown.
Amid the COVID-19 pandemic, there have been more than double as many suspected opioid-related overdoses in Wisconsin compared with last year, which health officials say can be potentially attributed to growing feelings of stress and isolation. Reported by The Associated Press, there have been 325 suspected overdoses from March through July 13 compared with 150 during this time frame last year, according to preliminary figures of Wisconsin’s Department of Health Services (DHS). DHS officials additionally highlighted that their analysis of calls to 211 Wisconsin, a state help line, has identified the pandemic, housing, mental health, and addiction as the top 4 concerns.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More